• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Expanding Access to Screening May Help Prevent Esophageal Cancer

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles Minimally invasive screening methods offer a more accessible, cost-effective way to detect Barrett’s esophagus early and help prevent esophageal cancer. Read More

HT-KIT Shows Activity in Rare KIT-Driven Cancers, Preclinical Data Finds

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles Preclinical data has showing compelling findings for HT-KIT among patients with rare and aggressive KIT-driven cancers, including GIST and some leukemias. Read More

Rebuilding Resilience: Navigating Aging and Exercise After CLL

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles After running the Boston Marathon at 67, I faced new limits from aging and chronic lymphocytic leukemia — but I’ve found ways to stay strong and resilient. Read More

Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles ATR-04 therapy is being investigated in the phase 1/2 ATR04-484 clinical trial for the treatment of EGFR inhibitor-associated rashes in lung cancer. Read More

Neoadjuvant Efti/Keytruda Combo Improves Tumor Fibrosis Rates in Sarcoma

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles Neoadjuvant efti and Keytruda plus radiotherapy met the EFTISARC-NEO trial’s primary end point by improving tumor fibrosis in soft tissue sarcoma. Read More

Radiation Therapy Eases Symptoms and Improves Targeting in Lung Cancer

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with modern techniques. Read More
« Older Entries

Recent Content

  • Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
  • Quadrivalent Meningococcal Vaccine Receives FDA Approval for Infants and Children With Meningococcal Disease
  • Expanding Access to Screening May Help Prevent Esophageal Cancer
  • HT-KIT Shows Activity in Rare KIT-Driven Cancers, Preclinical Data Finds
  • NLA 2025: Supporting Whole-Food Dietary Patterns vs Macronutrient Composition for Lipid Management
  • Rebuilding Resilience: Navigating Aging and Exercise After CLL
  • ASCO 2025: Cost Savings and Clinical Outcomes of Pre-Treatment DPYD Genotyping Before Fluoropyrimidine Therapy
  • Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer
  • Pharmacist Perspectives on ADC-Associated Toxicity in NSCLC Treatment
  • ASCO: Real-World Strategies for DPYD-Variant–Guided Fluoropyrimidine Dosing
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT